Winter P R, Wiesner G L, Finnegan J, Bartels D, LeRoy B, Chen P L, Sellers T A
Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, USA.
Am J Med Genet. 1996 Dec 2;66(1):1-6. doi: 10.1002/(SICI)1096-8628(19961202)66:1<1::AID-AJMG1>3.0.CO;2-X.
Little information is available about notifying individuals with a family history of cancer about their risk of cancer. With the recent identification of BRCA1, an important predisposition gene for breast and ovarian cancer, genetic testing is becoming available to high-risk women and their families. Some of these individuals, may not be aware of their family history and may be notified of their family history by medical personnel or biomedical investigators. This disclosure could be detrimental to the individual by changing their perception of risk, sense of privacy, or psychosocial well-being. Members of 544 breast cancer families are currently being contacted as part of an epidemiologic follow-up study at the University of Minnesota. Some family members were unaware of their relative's diagnosis and therefore, notification occurred when they were contacted by study personnel. To determine the impact of risk notification in this context, 376 male and female relatives of 160 breast cancer probands were surveyed to assess their prior knowledge of their family history of cancer, issues relating to study participation, and their concerns regarding the possibility of developing cancer. Following a telephone interview about family history, family members were administered a short, open-ended questionnaire. The majority of individuals (82%) were blood relatives of the proband and 71% were either first- or second-degree relatives. A proportion of blood relatives (24%) were not aware of their family history of breast cancer. More blood relatives (76%) than nonblood relatives (62%, P < 0.01) were aware of their family history. 43 respondents (12%) expressed specific concerns about participating in the large genetic follow-up study and 16 comments concerned privacy issues. Neither the reasons for participation nor an individual's concern about developing cancer was associated with gender of the respondent, relationship to the proband, or awareness of breast cancer in the family. Interestingly, individuals who were notified about their family history through the large follow-up study were no more likely than other family members to be more concerned about developing cancer. Understanding the privacy and psychosocial issues of family members who are informed about a family history of breast cancer may aid in developing appropriate guidelines for notification. Risk notification in this setting does not appear to have a significant impact on these family members.
关于告知有癌症家族史的个体其患癌风险的信息很少。随着最近BRCA1这一乳腺癌和卵巢癌重要易感基因的发现,高危女性及其家族可以进行基因检测。其中一些个体可能并不知晓自己的家族病史,可能会由医务人员或生物医学研究人员告知其家族病史。这种披露可能会改变他们对风险的认知、隐私感或心理社会幸福感,从而对个体造成不利影响。明尼苏达大学目前正在联系544个乳腺癌家族的成员,作为一项流行病学随访研究的一部分。一些家庭成员并不知道其亲属的诊断情况,因此,当研究人员与他们联系时才得到通知。为了确定在这种情况下风险告知的影响,对160名乳腺癌先证者的376名男性和女性亲属进行了调查,以评估他们对家族癌症病史的了解程度、与参与研究相关的问题以及他们对患癌可能性的担忧。在进行关于家族病史的电话访谈后,给家庭成员发放了一份简短的开放式问卷。大多数个体(82%)是先证者的血亲,71%是一级或二级亲属。一部分血亲(24%)不知道自己有乳腺癌家族病史。知晓家族病史的血亲(76%)比非血亲(62%,P<0.01)更多。43名受访者(12%)对参与大型基因随访研究表达了具体担忧,16条评论涉及隐私问题。参与研究的原因以及个体对患癌的担忧均与受访者的性别、与先证者的关系或家族中乳腺癌的知晓情况无关。有趣的是,通过大型随访研究得知家族病史的个体并不比其他家庭成员更担心患癌。了解被告知乳腺癌家族病史的家庭成员的隐私和心理社会问题,可能有助于制定合适的告知指南。在这种情况下的风险告知似乎对这些家庭成员没有显著影响。